Innovita Biological Technology Co., Ltd. (SHA:688253)

SHA:688253 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	7,117	4,070	4,948	3,403	3,241	-
Market Cap Growth	63.96%	-17.74%	45.41%	5.00%	-	-
Enterprise Value	5,228	2,227	3,088	1,921	1,811	-
Last Close Price	52.77	30.18	35.60	24.31	22.99	-
PE Ratio	78.72	27.87	20.04	19.56	21.51	-
PS Ratio	21.98	9.65	7.96	7.12	7.26	-
PB Ratio	3.40	2.00	2.48	1.85	1.92	-
P/TBV Ratio	3.44	2.01	2.49	1.85	1.93	-
P/FCF Ratio	-	-	18.37	14.01	47.17	-
P/OCF Ratio	-	-	16.20	13.10	25.64	-
EV/Sales Ratio	16.14	5.28	4.97	4.02	4.06	-
EV/EBITDA Ratio	-	12.42	11.94	9.56	16.30	-
EV/EBIT Ratio	53.12	13.87	12.87	10.73	19.15	-
EV/FCF Ratio	-	-	11.47	7.91	26.36	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.01	0.00
Debt / EBITDA Ratio	-	0.03	0.02	0.01	0.20	0.01
Debt / FCF Ratio	-	-	0.02	0.01	0.34	0.03
Net Debt / Equity Ratio	-0.90	-0.91	-0.95	-0.92	-0.88	-0.77
Net Debt / EBITDA Ratio	-	-10.29	-7.29	-8.43	-13.32	-3.89
Net Debt / FCF Ratio	-	-	-7.00	-6.97	-21.54	-13.30
Asset Turnover	0.14	-	0.29	0.24	0.33	0.41
Inventory Turnover	-	-	2.43	2.06	2.94	1.88
Quick Ratio	15.15	-	9.19	8.38	6.74	10.96
Current Ratio	15.58	-	9.50	8.70	7.15	12.42
Return on Equity (ROE)	4.40%	7.26%	12.87%	9.85%	12.41%	17.09%
Return on Assets (ROA)	2.73%	-	7.01%	5.58%	4.32%	10.46%
Return on Invested Capital (ROIC)	47.95%	98.78%	168.04%	87.88%	45.40%	91.02%
Return on Capital Employed (ROCE)	4.70%	-	12.00%	9.70%	5.60%	17.70%
Earnings Yield	1.28%	3.59%	4.99%	5.11%	4.65%	-
FCF Yield	-	-	5.44%	7.14%	2.12%	-
Dividend Yield	1.11%	-	1.57%	1.65%	0.72%	-
Payout Ratio	-	-	22.05%	13.02%	0.14%	41.63%
Buyback Yield / Dilution	-0.02%	-0.08%	-0.36%	-11.83%	-19.24%	-2.90%
Total Shareholder Return	1.08%	-0.08%	1.21%	-10.19%	-18.52%	-2.90%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.